Adrian has 26 years of experience in the drug discovery and contract research services areas, most recently as Director of In Vitro ADME at Charles River Laboratories. His group performs a variety of in vitro ADME assays, including custom and high-throughput (automated) studies. Adrian was previously an associate director at Agilux Labs (acquired by CRL), a senior investigator and group leader at ArQule, and a senior scientist at OsteoArthritis Sciences. His experience also includes protein biochemistry, lead optimization, and assay development/HTS.
Adrian received his Bachelor of Arts degree from Harvard University and his PhD in physiology and cell biology from Boston University. He has published over 30 papers and abstracts, and holds one patent.